Andrew Corey Paoletti is a notable inventor based in Saint Louis, MO (US). He has made significant contributions to the field of biomedical innovation, particularly in the diagnosis and treatment of neurological and neurodegenerative diseases. With a total of two patents to his name, Paoletti's work is paving the way for advancements in medical diagnostics.

Latest Patents

Paoletti's latest patents include "Methods for measuring concentrations of biomolecules" and "Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes." The first patent provides methods for measuring the absolute concentration of a biomolecule of interest in a subject, which may be implicated in various neurological conditions. It also includes a method for determining whether a therapeutic agent affects the in vivo metabolism of a central nervous system-derived biomolecule. The second patent focuses on methods to determine prognosis, diagnosis, or efficacy of a therapeutic regimen by using a detectable label to measure levels of alpha-synuclein, a protein associated with neurodegenerative diseases.

Career Highlights

Paoletti is currently associated with C2N Diagnostics LLC, where he continues to innovate in the field of diagnostics. His work is crucial in developing methods that can lead to better treatment options for patients suffering from neurological disorders.

Collaborations

One of his notable collaborators is Tim West, with whom he has worked on various projects aimed at enhancing diagnostic methods in the biomedical field.

Conclusion

Andrew Corey Paoletti is a distinguished inventor whose work in neurological diagnostics is making a significant impact. His innovative patents are essential for advancing the understanding and treatment of neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.